Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.
1Department of Medical Oncology, Gustave Roussy, Villejuif, France.
Cancer Res (2023) 83 (8_Supplement): LB215.
Abstract. TNG462 is a clinical-stage, MTA-cooperative PRMT5 inhibitor currently being evaluated in an ongoing phase I/II clinical trial for solid tumors with MTAP loss. Approximately 10-15% of all ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Cancer Res (2024) 84 (7_Supplement): LB055.
1The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, Texas. *Corresponding Author: Mikhail G Kolonin, Institute of Molecular Medicine, The ...
Cancer Res (2022) 82 (22_Supplement): PR006.
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
1Genentech, Inc., South San Francisco, CA. Search for other works by this author on: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback